Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Giuseppe Zerillo"'
Autor:
G Cannata, Roberto Valenza, Giovanni Spadafora, Federico Ingria, Carmelo Barbaccia, Nicola Gebbia, Antonio Testa, Salvatore Restivo, Giuseppe Zerillo, Vittorio Gebbia, Gianfranco Cupido
Publikováno v:
Oncology. 50:490-494
Forty patients with advanced squamous cell carcinoma of the head and neck (SCHNC) were treated with a combination of levofolinic acid 100 mg/m2+5-fluorouracil 375 mg/m2 in a 4-hour infusion plus cisplatin 20 mg/m2 in a 2-hour infusion for 5 consecuti
Autor:
Giuseppe Ricciardi, P.F. Conte, Masaharu Yoshihara, J. Limon, T. Jørgensen, B.E. Christensen, Sachio Fushida, Motofumi Yoshida, Ikuo Takahashi, Keizo Sugimachi, Koji Sumii, J. Schädelin, Claudio Rolim Teixeira, Enrico Colli, H. Hasle, D. Gardiner, Masahito Sugimura, Vittorio Gebbia, Salvatore Restivo, S. Barni, H. Birgens, M.A. Nagai, C.H. Wilder-Smith, A. Drivsholm, Yasunori Emi, Demetrios Minaretzis, M. Hrženjak, O.H.G. Wilder-Smith, Giuseppe Del Favero, Antonio Testa, M.M. Brentani, N.E. Hansen, Fabio Parazzini, Daniel Mordochovich, G. Seitz, Michael D. Melekos, L.A. Marques, G Cannata, M.M. Hansen, P. Lissoni, P.M. Suter, A. Borgeat, Yutaka Yonemura, Fumio Shimamoto, C Ferrara, M. Boogaerts, Daniela Basso, N. Blin, N.A. Peterslund, Elise Kokron, Mario Plebani, V. Jønsson, I. Kardaś, Noboru Konishi, Giovanni Spadafora, Yoshio Hiasa, Luca Tozzi, N. Žarković, Walter Paukovits, Lucia Desser, M. Forni, G.J.M. Maestroni, Tetsuya Kusumoto, S. Taesch, Francesco Mangano, Paola Fogar, M. Jurin, Bosco Lopez Saez, Z. Ilić, A. Rubagotti, Hiroto Nishioka, Roberto Valenza, J. Nikoskelainen, A. Ardizzoia, Marco Scatigna, Shinji Tanaka, Giuseppe Zerillo, Tamara Meggiato, Alexander Rehberger, Nicola Gebbia, Kouichiro Tsugawa, C. Welter, A. Niezabitowski, Gianfranco Cupido, A. Ferrant, Yoshiteru Kitahori, Diana Rinkevitch, Yehudith Ben-Arieh, Isao Hayashi, Federico Ingria, A. Conti, Ken Haruma, G. Gardin, Khalida P. Salim, Lael Best, Shunji Kohnoe, Shad S. Akhtar, I. Sklenar, G. Verhoef, D. Aravantinos, Goro Kajiyama, Walter Markiewicz, G. Schiffman, K.D. Christensen, Carmelo Barbaccia, R. Rosso, G. Bertelli, Angelo Burlina, G. Tancini, Stylianos Michalas, Zareefa A. Bano, G. Towse, Rebsdorf Pedersen, H. Torloni, Christina Tsionou, P. Pronzato, Antonis Keramopoulos, Yoshihiko Maehara, J. Ryś, Senra Varela, F. Rovelli, R. Lahtinen
Publikováno v:
Oncology. 50:I-VI
Autor:
Nicola Gebbia, Antonio Testa, Giovanni Spadafora, Anna Russo, Giuseppe Zerillo, Federico Ingria, Vittorio Gebbia, Roberto Valenza, Luciano Rausa
Publikováno v:
Scopus-Elsevier
After informed consent 21 patients with advanced head and neck cancer resistant to folinic acid/5-fluorouracil (FA/5FU + cisplatin) were treated with weekly FA/5FU plus low dose hydroxyurea (HU) to evaluate if HU could further modulate 5FU antineopla
Autor:
Nicola Gebbia, Giovanni Spatafora, Antonino Cimino, Sergio Palmeri, Vittorio Gebbia, Giuseppe Zerillo, Anna Russo, Pietro Ferrara, Federico Ingria, Tommaso Pastorello, Luciano Rausa
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 118:458-462
A group of 60 patients with advanced head/neck cancer were treated with high-dose folinic acid (500 mg/m-2/week-1) plus 5-fluorouracil (400 mg/m-2/week-1 on day 1, and cisplatin (20 mg/m-2/week-1) 24 h after folinic acid infusion was completed. Out o
Autor:
Federico Ingria, Nicola Gebbia, Roberto Valenza, Giuseppe Zerillo, Vittorio Gebbia, G Cannata, Salvatore Restivo, Antonio Testa
Publikováno v:
European journal of cancer (Oxford, England : 1990). (9)
Vinorelbine (VNR), 5′-nor-anhydrovinblastine, is a new semi-synthetic vinka alkaloid with selective affinity for mitotic microtubules, which has been shown to be active against several non small cell lung cancer lines in vitro [1]. VNR has been rep
Autor:
Giuseppe Zerillo, Federico Ingria, G Cannata, Salvatore Restivo, Antonio Testa, Nicola Gebbia, Gianfranco Cupido, Giovanni Spadafora, Roberto Valenza, Vittorio Gebbia, Carmelo Barbaccia, Calogero Cipolla
Publikováno v:
Medical oncology and tumor pharmacotherapy. 9(4)
Twenty-two patients with advanced head and neck carcinoma were treated with 5FU 400 mg-2 m-1 week and folinic acid 500 mg m-2 week-1 plus CDDP in escalating doses from 20 to 40 mg m-2 week-1 without forced diuresis. Reduced gluthatione at the dose of
Publikováno v:
Scopus-Elsevier
SummaryThis paper is an up-dated review of the role of systemic chemotherapy in the management of recurrent and/or metastatic head and neck carcinoma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e45072471447368a17e7d0fdd76aef9
http://www.scopus.com/inward/record.url?eid=2-s2.0-0026655803&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0026655803&partnerID=MN8TOARS